A RARE INHERITED RED BLOOD CELL ENZYME DEFICIENCY

Pyruvate Kinase Deficiency

A rare inherited enzyme deficiency in red blood cells, causing chronic haemolytic anaemia of variable severity. Managed with supportive care, transfusions when needed and specialist co-management.

Pyruvate kinase deficiency evaluation in Hyderabad
Rare GENETIC DISORDER
Variable Severity MILD TO SEVERE
Specialist Care ESSENTIAL

ABOUT THIS CONDITION

What is Pyruvate Kinase Deficiency

Pyruvate kinase (PK) deficiency is a rare inherited disorder in which red blood cells lack adequate amounts of pyruvate kinase, an enzyme essential for their energy production. Without enough energy, red blood cells break down prematurely, causing chronic haemolytic anaemia. The severity varies widely — some patients have mild anaemia that goes unnoticed for years, while others have severe anaemia from infancy requiring regular transfusions. Typical features include chronic tiredness, pallor, jaundice, dark urine, enlarged spleen and gallstones from increased bilirubin production. Severe cases in children may cause delayed growth and bone changes. Diagnosis involves blood tests showing haemolysis, specific enzyme assays and genetic testing. Treatment depends on severity and may include monitoring, folate supplementation, blood transfusions, removal of the spleen in selected cases, and newer disease-modifying therapies. Iron overload from repeated transfusions may require iron chelation. Dr. Patnam Pravallika Reddy provides initial evaluation and co-management with haematology at Lux Hospitals, Hyderabad.

SIGNS TO WATCH

Common Symptoms

⚠️

Symptoms that need attention

Chronic tiredness and weakness Pale skin and jaundice Dark urine due to red cell breakdown Enlarged spleen Gallstones from increased bilirubin Delayed growth in severe childhood cases Bone changes in severe forms

WHY IT HAPPENS

Causes & Risk Factors

CLINICAL DETAILS

KeyFacts

Diagnosis

Complete blood count, blood film, haemolysis markers, specific enzyme assay and genetic testing

Severity

Varies from mild to transfusion-dependent

Treatment

Supportive care, folate supplementation, transfusions and disease-modifying therapy in selected cases

Complications

Iron overload, gallstones and enlarged spleen

Specialist care

Haematology co-management essential

Hospital

Available at Lux Hospitals, Hyderabad — co-managed with haematology

HOW WE TREAT IT

Treatment Approach

Specialist Care with Severity-Based Management

The most effective approach is severity-based management ranging from observation and folate supplementation in mild cases to regular transfusions, iron chelation, splenectomy in selected patients, and newer disease-modifying therapies — all under specialist haematology care.

  1. 1

    Consultation & Assessment

    Dr. Pravallika reviews symptoms and family history, examines the patient and arranges blood tests with referral for specific enzyme and genetic testing.

  2. 2

    Treatment Planning

    A personalised plan is created in coordination with haematology based on severity and clinical course.

  3. 3

    Medical Management

    Folate supplementation, transfusion support when needed, iron chelation in transfused patients and disease-modifying therapy in selected cases.

  4. 4

    Recovery & Follow-up

    Long-term follow-up with haematology including monitoring of haemoglobin, iron levels and complications such as gallstones.

AVAILABLE TREATMENTS

Treatment Options

Folate Supplementation

Folate supplementation supports increased red blood cell production in patients with chronic haemolysis.

Blood Transfusions in Severe Cases (Referral for haematology)

Regular blood transfusions are needed in patients with severe anaemia, with the schedule determined by severity and growth needs.

Iron Chelation in Transfused Patients

Iron chelation therapy prevents and treats iron overload in patients receiving regular transfusions.

Splenectomy in Selected Patients (Referral for surgical evaluation)

Surgical removal of the spleen reduces red blood cell destruction and transfusion needs in selected patients.

Disease-Modifying Therapy in Selected Patients (Referral for haematology)

Newer disease-modifying therapy is now available for selected patients with PK deficiency, given under specialist care.

COMMON QUESTIONS

Frequently Asked Questions

Not sure about your condition?

Compassionate, confidential consultations — Book your appointment today.

WhatsApp Book Now Directions

Language